Scope of the Study
A left ventricular assist device is a pump that used for patients who have reached end-stage heart failure. It also known as a mechanical circulatory support device. It is an implantable mechanical pump that helps pump blood from the lower chambers of heart to the rest of body. It is implanted inside a personís chest to help a weakened heart pump blood. It doesnít replace the heart but it just helps it do its job.
The market study is being classified by Type (Transcutaneous Ventricular Assist Device and Implantable Ventricular Assist Device), by Application (Bridge-to-Transplant Therapy, Destination Therapy, Bridge-to-Recovery Therapy and Bridge-to-Candidacy Therapy) and major geographies with country level break-up.
Abiomed, Inc. (United States), Asahi Kasei Corporation (Japan), Abbott Laboratories (United States), Berlin Heart GmbH (Germany), Calon Cardio-Technology Ltd. (United Kingdom), CardiacAssist Technologies (United States), Jarvik Heart, Inc. (United States), Medtronic plc. (Ireland), ReliantHeart, Inc. (United States) and Terumo Medical Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Thoratec Corporation (United States) and Evaheart, Inc. (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Left Ventricular Assist Device market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Left Ventricular Assist Device market by Type, Application and Region.
On the basis of geography, the market of Left Ventricular Assist Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Flow, the sub-segment i.e. Pulsatile Flow will boost the Left Ventricular Assist Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- High Cardiovascular Disease Prevalence Leading To High Heart Failure Rates
- Rise in the Awareness among the People
- Continuous Adoption in Ventricular Assist Device
- Risk of Internal Bleeding and Infections
- Increasing Number of New Product Approval
- Growing Geriatric Population
- High Cost of Ventricular Assist Device Implantation
Market Leaders and their expansionary development strategies
Recently, Terumo completes the acquisition of vascular closure business and other assets of Abbott and ST. Jude Medical.
Key Target AudienceLeft Ventricular Assist Device Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase